Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Revue Medicale Suisse|May 30, 2015
[Dermatological implications of omalizumab, an anti-IgE antibody]Julie Di Lucca-ChrismentRevue Medicale Suisse|March 29, 2018
[Emerging systemic treatments of atopic dermatitis]Julie Di Lucca-Chrisment, Michel GillietRevue Medicale Suisse|November 21, 2019
[Cutaneous manifestations of nutritional deficiencies]Tatiana Schlomer, Julie Di Lucca, Pierre-Alexandre BartRevue Medicale Suisse|April 4, 2019
[From isolated cutaneous vasculitis to systemic disease : a diagnostic approach to purpura in the adult patient]Alice Horisberger, Jacqueline Ghosn, Julie Di Lucca, et al.Revue Medicale Suisse|May 21, 2016
[If you go looking for trouble you'll find it. Urticarial reactions to insects of our local areas]Sylvie Maitre, Amelie Kaeser, Julie Di Lucca, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 11, 2018
Netting Neutrophils Activate Autoreactive B Cells in LupusNicolas Gestermann, Jeremy Di Domizio, Roberto Lande, et al.Clinical Case Reports|May 22, 2019
Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B-cell lymphoma, leg typeMahdi Al Dhafiri, Flore Sicre de Fontbrune, Eduardo Marinho, et al.Dermatology (Basel, Switzerland)|February 27, 2016
PASS Syndrome: An IL-1-Driven Autoinflammatory DiseaseMathieu Leuenberger, Jeanne Berner, Julie Di Lucca, et al.Swiss Medical Weekly|September 8, 2021
Management of dupilumab-associated ocular surface diseases in atopic dermatitis patientsYan Guex-Crosier, Julie Di-Lucca, Peter Häusermann, et al.JAMA Dermatology|October 2, 2013
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcomaMaud Steff, Véronique Joly, Julie Di Lucca, et al.Pageof 2